Michael A. Kelly
Independent DirectorMr. Michael A. Kelly had been an Independent Director at NeoGenomics, Inc. since July 15, 2020 and serves as its Independent Director since September 2023. He is Director of nChroma Bio since December 2024. Mr. Kelly is a former senior executive of Amgen, Inc. From February 2003 until December 2017 and is acting as Founder & President of Sentry Hill Partners, LLC, a global life sciences transformation and management consulting business founded by him in January 2018. He has served as a member of our Board of Directors since November 2021. Mr. Kelly has more than two decades of executive experience as a senior leader in the life sciences industry serving in various strategic finance and operations positions at Amgen Inc., most as Senior Vice President, Global Business Services and Vice President & CFO, International Commercial Operations. He has also held senior and Chief Financial Officer positions at Biogen, Tanox and Monsanto Life Sciences. Mr. Kelly was an Independent Director at Amicus Therapeutics Inc. since December 2020 until April 27, 2026. He is Independent Director of DMC Global, Inc., joined in July 2020 and NeoGenomics Laboratories Inc. joined in July 2020. Previously, he served on the boards of Hookipa Pharma, Inc, from February 2019 until April 2023 and Aprea Therapeutics, Inc, from September 2020 until May 2022 and Chroma Medicine ( which merged with Nvelop Therapeutics in December 2024 to form nChroma Bio Inc.) a bio technology company, from February 2023 until December 2024. He also serves on the Council of Advisors and was the former audit committee chairman for Direct Relief, a humanitarian aid organization focused on health outcomes and disaster relief. Mr. Kelly has B.S.B.A. in Industrial Relations, Finance from Florida A & M University.
Positions
- Company NameNeoGenomics, Inc.Stock CodeNEOPositionIndependent DirectorColleagues
- APAnthony P. ZookCEO & Director
- LALynn A. TetraultIndependent Chair of the Board
- WSWarren StonePresident & COO
- EAElizabeth A. FloegelChief Digital & Information Officer
- GPGary PassmanChief People & Culture Officer
- AJAbhishek JainExecutive VP & CFO
- ALAlison L. HannahMember of Scientific Advisory Board
- SMStephen M. KanovskyIndependent Director
- Company NamePrime Medicine, Inc.Stock CodePRMEPositionIndependent Director
- Company NameDMC Global Inc.Stock CodeBOOMPositionIndependent DirectorColleagues
- JOJames O'LearyCEO, President & Executive Chairman of the Board
- EVEric V. WalterChief Financial Officer
- BABrett A. SegerChief Accounting Officer
- IGIan GrievesPresident & MD of DynaEnergetics
- JSJames SchladenPresident of Arcadia Products, LLC
- MAMichael A. KellyIndependent Director
- RIRuth I. DreessenIndependent Director
- OSOuma Sananikone-FletcherLead Independent Director
- JRJohn R. DoubmanIndependent Director
